Encore Healthcare Private Limited is part of a large privately owned pharmaceutical group, Encore Healthcare. Leaders in contract manufacturing of finished formulations and active pharmaceutical ingredients for multinational companies around the world, Encore Healthcare has recently vertically integrated into marketing and selling their own products under the name Encore Healthcare.
For the last two decades Encore Healthcare has grown to provide quality medication to regulated and semi-regulated markets world-wide with accreditation such as WHO and GMP. Encore Healthcare strives to provide the same quality medication as per international standards to the Indian patient.
In a nation brimming with over 1.2 billion people, where the doctor to patients ratio is 1 to 2000, quality healthcare providers are a necessity. In such a large pool every Indian patient deserves quality medicines at affordable prices. Hence, Encore Healthcare’s mission is to provide society with superior products and services that improve the quality of life and satisfy doctors' needs.
The Indian skin suffers from some of the most severe environmental aggressors in the world. These aggressors include pollution, UV light and excess heat. Dermatological conditions account for a substantial proportion of the global burden of disease in low and middle income countries including India.
Pollution can increase the risk of contact allergies or allergic rashes caused by some ingredients or allergens. It also can increase the risk of eczema. So overall, the excess pollution can result in Indian skin being more sensitive than Western skin.
An estimated 200 to 300 million people are suffering from acne in India.
India is close to the equator, making it more susceptible to the rays of the sun. This sunlight can cause an increase in pigmentation disorders and aging. In fact, the prevalence of melasma (a condition where patches of dark pigment occurs on the face) in India is higher than in Western countries.
Heat and sweat can also predispose one to fungal skin infections, which require immediate anti-fungal treatment.
As per the World Health Organization (WHO), mortality rate due to nutrition related factors is nearly 40 percent in developing countries, underscoring the need for nutraceutical products, to balance the nutritional intake of an individual. The Indian nutraceutical industry has seen a slew of product launches over the last five to seven years, with many more manufacturers, both domestic and international, looking to foray into the market.We at Encore Healthcare pride ourselves in our varied basket of quality nutraceuticals fit for the Indian patient
To be recognized by our customers, stakeholders and employees as a reliable healthcare provider
Meher Chambers, 3rd Floor,
R. K. Marg, Ballard Estate, Fort,
Mumbai – 400 001, Maharashtra, INDIA.
Tel No. + 91-22-4955 2000 / 4955 2001